An increase indicates the issuance of new preferred equity, while a decrease signals share repurchases or conversions into common stock.
This metric quantifies the total number of preferred stock shares currently held by all shareholders, excluding treasury...
Most large-cap pharmaceutical companies have simplified capital structures, so this is often zero or very low compared to common share counts.
other_preferred_stock_shares_outstanding| Q2 '23 | |
|---|---|
| Value | $49.09K |